| Name | STEAROYL ETHANOLAMIDE |
| Synonyms | CERAMID STEARAMIDE MEA STEAROYL ETHANOLAMIDE STEARIC ACID ETHANOLAMIDE N-(2-hydroxyethyl)stearamide STEARIC ACID MONOETHANOLAMIDE n-(2-hydroxyethyl)-octadecanamid Octadecanamide, N-(2-hydroxyethyl)- |
| CAS | 111-57-9 |
| EINECS | 203-883-2 |
| InChIKey | OTGQIQQTPXJQRG-UHFFFAOYSA-N |
| Molecular Formula | C20H41NO2 |
| Molar Mass | 327.55 |
| Density | 0.904±0.06 g/cm3(Predicted) |
| Melting Point | 103-104 °C(Solv: ethanol (64-17-5)) |
| Boling Point | 486.0±28.0 °C(Predicted) |
| Appearance | Morphological crystalline |
| pKa | 14.49±0.10(Predicted) |
| Storage Condition | −20°C |
| Physical and Chemical Properties | EPA Chemical Information N-(2-Hydroxyethyl)octadecanamide (111-57-9) |
| Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
| WGK Germany | 2 |
biological activity
Stearoylethanolamide is an endogenous cannabinoid compound with apoptosis-promoting activity.
target
Human Endogenous Metabolite
in vitro study
Stearoylethanolamide (SEA) is present in human, rat and mouse brain in amounts comparable with those of the endocannabinoid anandamide (arachidonoylethanolamide; AEA). Stearoylethanolamide is an endocannabinoid-like compound with pro-apoptotic activity, which is regulated by NO in a way opposite to that reported for AEA.